Literature DB >> 33858324

LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma.

Jiancheng Wang1, Gang Yin2, Hu Bian3, Jiangli Yang4, Pengcheng Zhou4, Kai Yan4, Cheng Liu4, Pei Chen4, Jun Zhu5, Zhi Li6, Tongqing Xue7.   

Abstract

BACKGROUND: Long non-coding RNA (lncRNA) XIST has been implicated in the progression of a variety of tumor diseases. The purpose of this study was to explore the molecular role of lncRNA XIST in human hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
METHODS: The expression levels of lncRNA XIST, miR-192 and TRIM25 in HBV-related HCC tissues and HepG2.2.15 cells were detected by qRT-PCR. Biological information and luciferin gene reporter assay were performed to detect the interaction among lncRNA XIST, miR-192 and TRIM25. CCk-8 assay, wound healing assay and colony formation assay were conducted to detect the proliferation and migration ability of HepG2.2.15 cells.
RESULTS: qRT-PCR results showed that the expression levels of lncRNA XIST were remarkably increased in HBV-related HCC tissues and HepG2.2.15 cells. In addition, miR-192 was a direct target gene of lncRNA XIST, and the expression of miR-192 and lncRNA XIST were negatively correlated. Moreover, overexpression of miR-192 observably inhibited the proliferation and migration of HCC cells, while overexpression of lncRNA XIST showed an opposite effect. Furthermore, TRIM25 was a direct target of miR-192, and lncRNA XIST could up-regulate the expression of TRIM25 by targeting miR-192.
CONCLUSION: LncRNA XIST could up-regulate the expression of TRIM25 by targeting and binding to miR-192, thus accelerating the occurrence and development of HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; Human hepatitis B virus; TRIM25; lncRNA XIST; miR-192

Year:  2021        PMID: 33858324     DOI: 10.1186/s10020-021-00278-3

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  44 in total

Review 1.  Hepatocellular carcinoma epidemiology.

Authors:  Cristina Bosetti; Federica Turati; Carlo La Vecchia
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-23       Impact factor: 3.043

Review 2.  Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression.

Authors:  Jesse M Engreitz; Noah Ollikainen; Mitchell Guttman
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-26       Impact factor: 94.444

3.  Corrigendum to "Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines" [Eur. J. Radiol. 101 (2018) 72-81].

Authors:  Carmen Ayuso; Jordi Rimola; Ramón Vilana; Marta Burrel; Anna Darnell; Ángeles García-Criado; Luis Bianchi; Ernest Belmonte; Carla Caparroz; Marta Barrufet; Jordi Bruix; Concepción Brú
Journal:  Eur J Radiol       Date:  2019-01-30       Impact factor: 3.528

4.  MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Authors:  Feng Fang; Rui-min Chang; Lei Yu; Xiong Lei; Shuai Xiao; Hao Yang; Lian-Yue Yang
Journal:  J Hepatol       Date:  2015-05-18       Impact factor: 25.083

Review 5.  Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.

Authors:  Carmen Ayuso; Jordi Rimola; Ramón Vilana; Marta Burrel; Anna Darnell; Ángeles García-Criado; Luis Bianchi; Ernest Belmonte; Carla Caparroz; Marta Barrufet; Jordi Bruix; Concepción Brú
Journal:  Eur J Radiol       Date:  2018-01-31       Impact factor: 3.528

6.  Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks.

Authors:  Hua-Sheng Chiu; David Llobet-Navas; Xuerui Yang; Wei-Jen Chung; Alberto Ambesi-Impiombato; Archana Iyer; Hyunjae Ryan Kim; Elena G Seviour; Zijun Luo; Vasudha Sehgal; Tyler Moss; Yiling Lu; Prahlad Ram; José Silva; Gordon B Mills; Andrea Califano; Pavel Sumazin
Journal:  Genome Res       Date:  2014-11-05       Impact factor: 9.043

Review 7.  lncRNA/MicroRNA interactions in the vasculature.

Authors:  M D Ballantyne; R A McDonald; A H Baker
Journal:  Clin Pharmacol Ther       Date:  2016-03-31       Impact factor: 6.875

Review 8.  World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.

Authors:  Catherine de Martel; Delphine Maucort-Boulch; Martyn Plummer; Silvia Franceschi
Journal:  Hepatology       Date:  2015-10       Impact factor: 17.425

9.  Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.

Authors:  Shuzhen Chang; Binhe Chen; Xiaoyan Wang; Keqin Wu; Yuqiu Sun
Journal:  BMC Cancer       Date:  2017-04-07       Impact factor: 4.430

10.  MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion.

Authors:  Volker Ast; Theresa Kordaß; Marcus Oswald; Amol Kolte; David Eisel; Wolfram Osen; Stefan B Eichmüller; Alexander Berndt; Rainer König
Journal:  Oncotarget       Date:  2018-10-30
View more
  8 in total

1.  LncRNA00978 contributes to growth and metastasis of hepatocellular carcinoma cells via mediating microRNA-125b-5p/SOX12 pathway.

Authors:  Zhiqing Cheng; Limei Gong; Qinghe Cai
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  LncRNA SLC16A1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-411/MITD1 axis.

Authors:  Chun Duan
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

Review 3.  MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.

Authors:  Janusz Matuszyk
Journal:  Mol Med       Date:  2022-08-03       Impact factor: 6.376

Review 4.  Long noncoding RNAs in hepatitis B virus replication and oncogenesis.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 5.  When does hepatitis B virus meet long-stranded noncoding RNAs?

Authors:  Bingxin Lei; Hongxiao Song; Fengchao Xu; Qi Wei; Fei Wang; Guangyun Tan; Haichun Ma
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

Review 6.  TRIM proteins in hepatocellular carcinoma.

Authors:  Kan Lu; Yonglong Pan; Zhao Huang; Huifang Liang; Ze-Yang Ding; Bixiang Zhang
Journal:  J Biomed Sci       Date:  2022-09-13       Impact factor: 12.771

Review 7.  Circulating Extracellular Vesicles Carry Immune Regulatory miRNAs and Regulate Vaccine Efficacy and Local Inflammatory Response After Vaccination.

Authors:  Hiroyuki Oshiumi
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

8.  Long noncoding RNA XIST regulates brown preadipocytes differentiation and combats high-fat diet induced obesity by targeting C/EBPα.

Authors:  Chunyan Wu; Shu Fang; Huijian Zhang; Xiaoqiang Li; Yuejun Du; Yudan Zhang; Xiaochun Lin; Ling Wang; Xiaoqin Ma; Yaoming Xue; Meiping Guan
Journal:  Mol Med       Date:  2022-01-21       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.